Daily FNArena News - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Amcor posted a solid quarter but all eyes are on the company’s proposed takeover of the larger Berry Global Group

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Gains across consumer discretionary and financials helped the ASX200 outperform international equities and record a 4.6% gain in January, but tariff uncertainty clouds the outlook

The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a positive for the sleep apnoea industry

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Tomorrow’s release is expected to reveal another strong quarter from ResMed

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Analysts anticipate buyback announcements during the February reporting season will help sustain ongoing share price gains for the big three general insurers on the ASX